Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy-Reference-Cited by-同舟云学术

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy

Published:2017-06-20 Issue:1 Volume:82 Page:44-56
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Ebenezer Gigi J.¹,Liu Ying¹,Judge Daniel P.²,Cunningham Kelly¹,Truelove Shaun³,Carter Noel D.¹,Sebastian Blessan¹,Byrnes Kelly¹,Polydefkis Michael¹

Affiliation:

1. Department of Neurology; Johns Hopkins University

2. Division of Cardiology; Johns Hopkins University

3. Department of Epidemiology; Johns Hopkins Bloomberg School of Public Health; Baltimore MD

Funder

Pfizer

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.24972/fullpdf

Reference44 articles.

1. Familial amyloid polyneuropathy;Plante-Bordeneuve;Lancet Neurol,2011

2. Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey);Maurer;J Am Coll Cardiol,2016

3. Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis;Damy;J Cardiovasc Transl Res,2015

4. Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction;Ton;Clin Med Insights Cardiol,2014

5. Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history study;Adams;Neurology,2015

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A description of variant transthyretin amyloidosis (ATTRv) stage 1 patients and asymptomatic carriers in Spain: the EMPATIa study;Orphanet Journal of Rare Diseases;2024-09-06

2. T2-relaxometry in a large cohort of hereditary transthyretin amyloidosis with polyneuropathy;Amyloid;2024-09-02

3. Amyloid Neuropathy: From Pathophysiology to Treatment in Light‐Chain Amyloidosis and Hereditary Transthyretin Amyloidosis;Annals of Neurology;2024-06-24

4. Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis;Journal of the Peripheral Nervous System;2024-05-05

5. A systematic review to explore patients’ MS knowledge and MS risk knowledge;Neurological Sciences;2024-05-03